PTHL Pheton Total Asset Value of Company

PTHL (ftzy.com.cn) - company brandmark

Pheton Holdings Ltd (PTHL) relies on external contractors for production and research, as confirmed by the price action chronology on GURU.Markets, where total assets amount to 3.23. Trade disputes between Washington and Beijing are weighing on the business, hindering global expansion. Additionally, software development costs and uncertainty regarding the certification of oncology systems in the PRC are constraining profits.

PTHL (Pheton Holdings) Company Total Assets history from 09/06/2024 to 01/16/2026
Manufactured products of Pheton Holdings Limited

The creditworthiness assessment of Pheton Holdings Ltd (PTHL) is based on an analysis of the material base, which is reverse-calculated here via return on assets to decouple fundamental scale from market volatility. This metric reflects the value of production capacities, including automated Chinese radiotherapy laboratories, allowing investors to monitor the company's actual resource volume through total assets as a counterweight to speculative price fluctuations.

Key competitors

HLN (haleon.com) - Aggregate Company Assets|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets BioHarvest Sciences Inc BHST|Aggregate Company Assets eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Aggregate Asset Value|Aggregate Company Assets Entera Bio ENTX|HYFT (MindWalk Holdings, Inc.) - Total Asset Value of Company|ABVC BioPharma Inc - Company Total Assets|Aggregate Asset Value CPIX (Cumberland Corp)|QNTM: Company Total Assets|Company Assets fibrogen.com (FGEN)|Cumulative Company Assets TELO|RANI (Rani Therapeutics Inc) - Aggregate Business Assets|Aggregate Company Assets Synergy CHC Corp (SNYR)|RLYB - Company Assets|Aggregate Company Assets Lexaria Bioscience Corp. LEXX|PULM: Total Business Assets|APM: Cumulative Company Assets|Aggregate Asset Value LYRA (Lyra Therapeutics Inc.)|IBO: Company Total Assets|TNF Pharmaceuticals, Inc. - Aggregate Asset Value|Aggregate Company Assets cbdMD Inc.|Company Assets painreform.com PRFX|Aggregate Company Assets Altamira Therapeutics (CYTO)|Aggregate Company Assets LIPO (Lipella Pharmaceuticals Inc)|Company Total Assets OPTN (Optinose)|PIRS: Total Business Assets|Procaps Group S.A. - Company Total Assets|Company Total Asset Base petrospharma.com PTPI|Qilian International Holding (QLI) - Aggregate Company Assets|Total Business Assets SLRN|TFFP (TFF Pharma) - Company Total Assets